John C. Mathison
7Patents
5h-index
5Co-inventors
48Inventor score
Filing activity: Oct 25, 1994 → Sep 3, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5820858A | Methods and compositions for inhibiting CD14 mediated cell activation | Physics | 14 | Expired |
| US5730980A | Methods and compositions for ameliorating the symptoms of sepsis | Human Necessities | 12 | Expired |
| US6444206B1 | Methods and compositions for inhibiting CD14 mediated cell activation | Physics | 7 | Expired |
| US6045795A | Methods and compositions for ameliorating the symptoms of sepsis | Human Necessities | 7 | Expired |
| US7326569B2 | Hybrid cells producing monoclonal anti-CD14 antibodies | Physics | 5 | Expired |
| US6297049A | Methods and compositions for ameliorating the symptoms of sepsis | Human Necessities | 2 | Expired |
| US6495332B2 | Methods and compositions for ameliorating the symptoms of sepsis | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.